• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

JFR 2008 puts emphasis on high-tech imaging

Article

High-tech imaging was the central theme of the 56th Journées Françaises de Radiologie (JFR), held in Paris from 24 to 28 October. Left: DI Europe's editorial advisor, Prof. Andy Adam from London, was one of three honorary members at the congress.

High-tech imaging was the central theme of the 56th Journées Françaises de Radiologie (JFR), held in Paris from 24 to 28 October. Left: DI Europe's editorial advisor, Prof. Andy Adam from London, was one of three honorary members at the congress. The other two honorary members were Prof. Lluís Donoso Bach from Barcelona and Dr. James Thrall from Boston, Massachusetts. Middle: The general assembly of the Fédération Nationale des Médecins Radiologues took place during the JFR. FNMR president Dr. Jacques Niney informed attendees about the ongoing reforms and reductions in fees that might lie ahead. Right: The Société Française de Radiologie's reception took place at the Hôtel des Invalides. (Photos by Dr. Robert Lavayssière)

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.